17
Clinimax Difficil-S Part A Version 3.1, Supersedes Version 3, 29/0716 Date of issue/Revision: 06/12/16 1 of 17 SAFETY DATA SHEET Difficil-S Part A SECTION 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1 Product Identification Product Name Difficil-S Part A Product Type Powder Product Component of Surface Disinfectant. Difficil-S Powders A and B are added at 1:400 in water, the resultant working solution contains approximately 300ppm chlorine dioxide in solution. 1.2. Relevant Identified uses of substance and uses advised against The material is intended to be mixed with Difficil-S Part B and water to make a Surface Disinfectant. The material should only be used in conjunction with Clinimax Difficil-S Part B and mixed in accordance with the manufacturer’s instructions using manufacturer’s specified mixing equipment. 1.3. Details of supplier Clinimax Limited Shepherds Grove West Stanton Bury ST Edmunds Suffolk IP31 2AR UK Telephone +44 (0)1359 252181 Email address of person responsible for this SDS [email protected] 1.4. Emergency telephone number +44 (0)1359 252181 Opening Hours 9.00am to 4.30pm, Mon - Fri SECTION 2. HAZARDS IDENTIFICATION 2.1 Classification according to Regulation (EC) No 1272/2008 [CLP] Ox Sol. 3 H272 may intensify fire; oxidiser Acute Tox. 4 H302 Harmful if swallowed Acute Tox 2 H330 Fatal if inhaled Skin Corr. 1B - Causes severe skin burns and eye damage STOT RE 2 - May cause damage to organs (spleen) through prolonged or repeated exposure Aquatic Acute 1 H400 Very toxic to aquatic life.

Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 1 of 17

SAFETY DATA SHEET

Difficil-S Part A

SECTION 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

1.1 Product Identification Product Name Difficil-S Part A

Product Type Powder

Product Component of Surface Disinfectant. Difficil-S Powders A and B are added at 1:400 in water, the resultant working solution contains approximately 300ppm chlorine dioxide in solution.

1.2. Relevant Identified uses of substance and uses advised against

The material is intended to be mixed with Difficil-S Part B and water to make a Surface Disinfectant. The material should only be used in conjunction with Clinimax Difficil-S Part B and mixed in accordance with the manufacturer’s instructions using manufacturer’s specified mixing equipment.

1.3. Details of supplier Clinimax Limited Shepherds Grove West Stanton Bury ST Edmunds Suffolk IP31 2AR UK Telephone +44 (0)1359 252181

Email address of person responsible for this SDS

[email protected]

1.4. Emergency telephone number +44 (0)1359 252181 Opening Hours 9.00am to 4.30pm, Mon - Fri

SECTION 2. HAZARDS IDENTIFICATION

2.1 Classification according to Regulation (EC) No 1272/2008 [CLP]

Ox Sol. 3 H272 – may intensify fire; oxidiser Acute Tox. 4 H302 – Harmful if swallowed Acute Tox 2 H330 – Fatal if inhaled Skin Corr. 1B - Causes severe skin burns and eye damage STOT RE 2 - May cause damage to organs (spleen) through prolonged or repeated exposure Aquatic Acute 1 H400 – Very toxic to aquatic life.

Page 2: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 2 of 17

Aquatic Chronic 3 H412 - Harmful to aquatic life with long-lasting effects

For full text of CLP/GHS phrases: see SECTION 16. For further details on the health effects and symptoms: see SECTION 11.

2.2 Labelling in accordance with the classification Labelling and Packaging Regulation (EC) 1272 /2008

DANGER

Hazard Statements H272 - May Intensify fire; oxidiser H302 - Harmful if swallowed H314 - Causes severe skin burns and eye damage H330 - Fatal if inhaled H373 - May cause damage to organs (spleen) through prolonged or repeated exposure H400 - Very toxic to aquatic life H412 - Harmful to aquatic life with long-lasting effects

Precautionary Statements P210 - Keep away from heat P221 - Avoid combustible materials and acids P260 - Do not breathe dust/fume P273 - Avoid release to the environment. Refer to special instructions/safety data sheet P280 - Wear protective gloves/clothing/eye/face protection P302 + P352 - IF ON SKIN: Wash with plenty of soap and water P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing

Hazardous Ingredients Sodium Chlorite, Sodium Dodecyl Sulphate

Supplemental label requirements EUH032 - Contact with acids liberates toxic gas EUH071 - Corrosive to the respiratory tract

Special packaging requirements

Containers to be fitted with child-resistant fastenings

Not applicable.

Tactile warning of danger Not applicable.

2.3 Other Hazards Handling and/or processing of this material may generate a dust which is corrosive to the respiratory tract. Fine dust clouds may form explosive mixtures with air.

Page 3: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 3 of 17

SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

3.1 Substance

Product/ingredient name Identifiers % Classification Type

Regulation (EC) No

1272/2008

sodium chlorite EC: 231-836-6 CAS: 7758-19-2

35-50 Acute Tox. 3, H301 Acute Tox. 2, H310 Acute Tox. 1, H330 Skin Corr. 1B STOT RE 2 H373 Aquatic Acute 1, H400 Aquatic Chronic 3 H412

[1]

Sodium dodecyl sulphate EC: 205-788-1 CAS: 151-21-3

10-20 Acute Tox. 4, H302 Skin Irrit. 2, H315 Eye Dam. 1 H318 Aquatic Acute 3, H412

[1]

Sodium carbonate EC: 207-838-8 CAS: 497-19-8 Index: 011-005-00-2

<10 Eye Irrit. 2, H319

[1]

See Section 16 for the full text of the H phrases declared above.

There are no additional ingredients present which, within the current knowledge of the supplier and in the concentrations applicable, are classified as hazardous to health or the environment, are PBTs or vPvBs or have been assigned a workplace exposure limit and hence require reporting in this section. Type - [1] Substance classified with a health or environmental hazard.

Page 4: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 4 of 17

SECTION 4. FIRST AID MEASURES

4.1 Description of first aid measures Eye contact Seek medical attention immediately. Flush eyes with plenty of water,

also under eyelids. Check for contact lenses and remove if present and easy to do. Continue to rinse for at least 10 minutes and consult an eye physician immediately. Chemical burns must be treated promptly by a physician.

Inhalation Seek medical attention immediately. Remove victim to fresh air and keep at rest in a position comfortable for breathing. If not breathing perform artificial respiration with the aid of a pocket mask and contact the emergency services.

Skin contact Seek medical attention immediately. Remove contaminated clothing and shoes and flush contaminated skin with plenty of water. Continue to rinse for at least 10 minutes. Chemical burns must be treated promptly by a physician. Wash clothing before reuse. Clean shoes thoroughly before reuse.

Ingestion Seek medical attention immediately. Wash out mouth with water. Remove dentures if any. Remove victim to fresh air and keep at rest in a position comfortable for breathing. If material has been swallowed and the exposed person is conscious, give small quantities of water to drink. Stop if the exposed person feels sick as vomiting may be dangerous. Do NOT induce vomiting. If vomiting occurs, the head should be kept low so that vomit does not enter the lungs. Chemical burns must be treated promptly by a physician. Never give anything by mouth to an unconscious person. If unconscious, place in recovery position and contact the emergency services. Maintain an open airway. Loosen tight clothing such as a collar, tie, belt or waistband.

Protection of first aiders No action shall be taken involving any personal risk or without suitable training. The rescuer should wear the appropriate PPE and follow all precautions to protect themselves and prevent contamination.

4.2 Most important symptoms and effects, both acute and delayed

Potential acute health effects

Eye contact Corrosive to eyes. Causes burns.

Inhalation Very toxic by inhalation. May give off gas, vapour or dust that is very irritating or corrosive to the respiratory system.

Skin contact Corrosive to the skin. Causes burns. Toxic in contact with skin.

Ingestion Toxic if swallowed. May cause burns to mouth, throat and stomach.

Over-exposure signs /symptoms Eye contact Adverse symptoms may include the following:

pain

watering

redness

Page 5: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 5 of 17

Inhalation Adverse symptoms may include the following:

respiratory tract irritation

coughing

Skin contact Adverse symptoms may include the following:

pain or irritation

redness

blistering may occur

Ingestion Adverse symptoms may include the following:

stomach pains, burns to the mouth and throat

4.3 Indication of any immediate medical attention and special treatment needed

Notes to physician Treat symptomatically. Contact poison treatment specialist immediately if large quantities have been ingested or inhaled.

Specific treatments No specific treatment.

SECTION 5. FIREFIGHTING MEASURES

5.1 Extinguishing media Suitable extinguishing media

Use dry chemical powder.

Unsuitable extinguishing media

Do not use water jet.

5.2 Special hazards arising from the substance or mixture

Hazards from the substance or mixture

Contact with combustible material may cause fire. Fine dust clouds may form explosive mixtures with air. This material increases the risk of fire and may aid combustion.

Hazardous thermal decomposition products

Decomposition products may include the following materials:

sulphur oxides

halogenated compounds

chlorine dioxide gas

5.3 Advice for firefighters

Special protective actions for fire-fighters

Promptly isolate the scene by removing all persons from the vicinity of the incident if there is a fire. No action shall be taken involving any personal risk or without suitable training. Move containers from fire area if this can be done without risk. Use water spray to keep fire-exposed containers cool. This material is very toxic to aquatic organisms. Fire water contaminated with this material must be contained and prevented from being discharged to any waterway, sewer or drain.

Page 6: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 6 of 17

SECTION 6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures For non-emergency personnel

No action shall be taken involving any personal risk or without suitable training. Evacuate surrounding areas. Keep unnecessary and unprotected personnel from entering. Do not touch or walk through spilt material. Shut off all ignition sources. No flares, smoking or flames in hazard area. Do not breathe dust. Provide adequate ventilation. Wear appropriate respirator when ventilation is inadequate. Put on appropriate personal protective equipment.

For emergency responders

If specialised clothing is required to deal with the spillage, take note of any information in Section 8 on suitable and unsuitable materials. See also Section 8 for additional information on hygiene measures.

6.2 Environmental precautions

Avoid dispersal of spilt material and runoff and contact with soil, waterways, drains and sewers. Inform the relevant authorities if the product has caused environmental pollution (sewers, waterways, soil or air). Water polluting material. May be harmful to the environment if released in large quantities.

6.3 Methods and materials for containment and cleaning up

Small spill Less than 5 sachets. Wear gloves and eye safety wear as outlined in section 8. Avoid contact with the skin and eyes. Move containers from spill area. Sweep up material and place in a designated, labelled waste container. Place spilt material in an appropriate container for disposal. Do not use combustible absorbents, e.g. paper towels or saw dust to absorb spillages.

Large spill For large-scale spills of the powder ensure full personal protective equipment is worn. Avoid contact with the skin and eyes. Move containers from spill area. If unopened sachets are spilt these can be replaced in the container if undamaged and dry. Do not attempt to neutralise the spillage with acids. Avoid allowing the spilled material to get wet or using water to clean up spillages or residues, unless the quantity remaining is very small. Sweep up material and place in a designated, labelled waste container. Avoid creating dusty conditions and prevent wind dispersal. Do not use combustible absorbents, e.g. paper towels or saw dust to absorb spillages. Dispose of via a licensed waste disposal contractor. Note: see section 1 for emergency contact information and section 13 for waste disposal.

6.4 Reference to other sections

See Section 1 for emergency contact information. See Section 8 for information on appropriate personal protective equipment. See Section 13 for additional waste treatment information.

Page 7: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 7 of 17

SECTION 7. HANDLING AND STORAGE

7.1 Precautions for safe handling Protective measures Protective measures Put on appropriate personal protective equipment (see Section 8). Do

not get in eyes or on skin or clothing. Do not breathe dust. Do not ingest. Avoid release to the environment. Use only with adequate ventilation. Keep sachets in original box together with instructions for use and refer to these when handling. Keep away from acids. Keep away from combustible material.

Advice on general occupational hygiene

Eating, drinking and smoking should be prohibited in areas where this material is handled, stored and processed. Workers should wash hands and face before eating, drinking and smoking. Remove contaminated clothing and protective equipment before entering eating areas. See also Section 8 for additional information on hygiene measures.

7.2 Conditions for safe storage, including any incompatibilities

Store in accordance with local regulations. Store in a segregated and approved area. Store in original container protected from direct sunlight in a dry, cool and well ventilated area, away from incompatible materials (see section 10) and food and drink. Eliminate all ignition sources. Separate from acids. Separate from oxidizing materials. Separate from reducing agents and combustible materials. Do not store in unlabelled containers or packaging. Use appropriate containment to avoid environmental contamination.

7.3 Specific end use(s)

Recommendations Use only as a cleaning disinfectant and must be mixed with part B and water in accordance with the manufacturer’s instructions.

Industrial sector specific solutions

For use in the healthcare industry

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control Measures Occupational exposure limits

Chlorine Dioxide: Long term exposure limit 0.1 ppm, 0.28mg.m³ (8-hr TWA reference period), short term exposure limit 0.3 ppm, 0.84mg.m³ (15 minute reference period).

Recommended monitoring procedures

None identified.

Derived effect levels No DNELs available.

Predicted effect concentrations

No PNECs available.

8.2 Exposure controls

Appropriate engineering controls

Good general ventilation should be sufficient to control worker exposure to airborne contaminants. If dust is generated and ventilation is inadequate, use respirator that will protect against dust or local exhaust ventilation conforming to European (EN) Standards.

Page 8: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 8 of 17

Only use mixing and dispensing equipment specified by the manufacturer.

Individual protection measures

Hygiene measures Wash hands and forearms and any other contaminated area thoroughly after handling this chemical product, before eating, smoking and using the lavatory and at the end of the working period. Appropriate techniques should be used to remove potentially contaminated clothing. Wash contaminated clothing before reusing. Ensure that eyewash stations and safety showers are close to the workstation location.

Eye/face protection Safety goggles or face shield giving complete eye protection complying with the European (EN) Standard EN 166 should be used when opening and mixing contents of the sachets. This is necessary to avoid exposure to mists or dusts.

Skin protection :

Hand protection Chemical-resistant Nitrile or PVC gloves complying with the European (EN) Standards EN-374 should be worn at all times when handling this chemical product during both mixing and end use of the disinfecting cleaning solution.

Body protection Personal protective equipment for the body complying with European (EN) Standards should be selected based on the task being performed and the risks involved and should be approved by a specialist before handling this product. For normal use the following is advisable for both mixing and use of the working solution: Recommended: Safety Overalls or Safety Apron.

Respiratory protection In case of insufficient ventilation, wear suitable respiratory equipment complying with European (EN) Standards EN-149.

Environmental exposure controls

Emissions from ventilation or work process equipment should be checked to ensure they comply with the requirements of environmental protection legislation. In some cases, fume scrubbers, filters or engineering modifications to the process equipment will be necessary to reduce emissions to acceptable levels.

SECTION 9: PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties Appearance

Physical state Solid [powder]

Colour White

Odour None

Odour Threshold None

pH 10.6 [Conc. (% w/w): 1%]

Melting point/freezing point

Not available.

Page 9: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 9 of 17

Initial boiling point and boiling range

Not available.

Flash point Not applicable.

Evaporation rate Not available.

Flammability (solid, gas) Not applicable.

Burning time Not available.

Burning rate Not available.

Vapour pressure Not available.

Vapour density Not available.

Relative density Not available.

Partition coefficient: noctanol/ water

Not available.

Auto-ignition temperature >300oC

Decomposition temperature

>200oC

Viscosity Not applicable.

Explosive properties Not classified as explosive

Oxidising properties Oxidising solid, corrosive.

9.2 Other information

No additional information.

SECTION 10. STABILITY AND REACTIVITY

10.1 Reactivity

No specific test data related to reactivity available for this product or its ingredients.

10.2 Chemical stability The product is stable.

10.3 Possibility of hazardous reactions

Contact with acids may liberate toxic gas (chlorine dioxide). Contact with combustible materials may cause fire or intensify fires. May react violently with highly flammable materials causing fire and explosion.

10.4 Conditions to avoid Avoid the creation of dust when handling and avoid all possible sources of ignition (spark or flame). Prevent dust accumulation. Avoid contact with strong acids, alkali or oxidising agents. Keep dry, except for when preparing solutions.

10.5 Incompatible materials

Reactive or incompatible with the following materials:

acids

oxidizing materials

combustible materials

reducing materials

10.6 Hazardous decomposition products

Contact with acids liberates very toxic gas (chlorine dioxide).

Page 10: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 10 of 17

SECTION 11. TOXICOLOGICAL INFORMATION

11.1 Information on toxicological effects Acute toxicity

Product/ingredient name

Result Species Dose Exposure

sodium chlorite LC50 Inhalation Dust LD50 Dermal LD50 Oral

Rat Rabbit Rat

230 mg/m3 134 mg/kg 165 mg/kg

4 hours - -

Sodium dodecyl sulphate LD50 Oral Rat 1288 mg/kg -

Sodium carbonate LD50 Oral Rat 4090 mg/kg -

Conclusion/Summary

Not available.

Product/ingredient name

Result Species Score Dose Observation

sodium dodecyl sulphate

Eyes - Mild irritant Rabbit - 250 Micrograms

-

Eyes - Moderate irritant

Rabbit - 24 hours 100 milligrams

-

Eyes - Moderate irritant

Rabbit - 10 milligrams

-

Skin - Mild irritant Dog - 24 hours 25 milligrams

-

Skin - Mild irritant Guinea pig - 24 hours 25 milligrams

-

Skin - Mild irritant Human - 504 hours 0.3

Percent

-

Skin - Mild irritant Human - 24 hours 0.06 Percent

-

Skin - Mild irritant Human - 22 hours 10 Percent

-

Skin - Mild irritant Human - 47 hours 0.5 Percent

-

Skin - Mild irritant Human - 18 hours 2 Percent

-

Skin - Moderate irritant Human - 48 hours 3 Percent

-

Skin - Moderate irritant Human - 24 hours 0.1 Percent

-

Skin - Moderate irritant Mouse - 24 hours 25 milligrams

-

Skin - Mild irritant Pig - 24 hours 25 milligrams

-

Page 11: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 11 of 17

Skin - Mild irritant Rabbit - 24 hours 50 milligrams

-

Skin - Moderate irritant Rabbit - 24 hours 25 milligrams

-

Skin - Mild irritant Human - 2 hours 2 Percent

-

sodium carbonate Eyes - Mild irritant Rabbit - 50 milligrams

-

Eyes - Moderate irritant

Rabbit - 50 milligrams

-

Eyes - Severe irritant Rabbit - 50 milligrams

-

Eyes - Severe irritant Rabbit - 24 hours 500 milligrams

-

Conclusion/Summary

Not available.

Sensitisation

Conclusion/Summary None of the components are considered to be sensitising.

Mutagenicity

Conclusion/Summary None of the components are considered to be mutagenic.

Carcinogenicity

Conclusion/Summary None of the components are considered to be carcinogenic.

Reproductive toxicity Conclusion/Summary None of the components are considered to exhibit reproductive toxicity.

Teratogenicity

Conclusion/Summary None of the components are considered to exhibit developmental toxicity.

Information on the likely routes of exposure

Skin contact and inhalation of dust most likely routes.

Potential acute health effects

Eye contact Corrosive to eyes. Causes burns.

Inhalation Very toxic by inhalation. May give off gas, vapour or dust that is very irritating or corrosive to the respiratory system.

Skin contact Corrosive to the skin. Causes burns. Toxic in contact with skin.

Ingestion Toxic if swallowed. May cause burns to mouth, throat and stomach.

Delayed and immediate effects and also chronic effects from short and long term exposure

Short term exposure

Potential immediate effects

Not available.

Potential delayed effects

Not available.

Long term exposure

Potential immediate effects

Not available.

Page 12: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 12 of 17

Potential delayed effects

Not available.

Potential chronic health effects

Conclusion/Summary Not available.

Potential delayed effects

Not available.

General Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation. Sodium chlorite is classified as STOT RE 2, this may cause damage to organs (spleen) through prolonged or repeated exposure

SECTION 12. ECOLOGICAL INFORMATION

12.1 Toxicity

Product/ingredient name

Result Species Exposure

sodium chlorite Acute EC50 1.32 ppm Fresh water

Algae - Pseudokirchneriella subcapitata

4 days

Acute EC50 0.025 ppm Fresh water

Daphnia - Daphnia magna - <24 hours

48 hours

Acute LC50 75 ppm Marine water

Fish - Cyprinodon variegatus 96 hours

sodium dodecyl sulphate

Acute EC50 15 mg/L Marine water

Algae – Dunaliella tertiolecta - Exponential growth phase

72 hours

Acute EC50 8800 ug/L Fresh water

Algae - Pseudokirchneriella subcapitata

96 hours

Acute EC50 5 to 10 ppm Marine water

Aquatic plants - Macrocystis pyrifera - Young

4 days

Acute LC50 1500 ug/L Marine water

Crustaceans - Artemia sp. 48 hours

Acute LC50 1500 ug/L Marine water

Daphnia - Ceriodaphnia dubia - Neonate

48 hours

Acute LC50 590 ug/L Fresh water

Fish - Cirrhinus mrigala - Larvae - 2 days - 4.5 mm - 51 mg

96 hours

Chronic NOEC 0.15 mg/L Fresh Water

Fish - Oncorhynchus mykiss - Juvenile (Fledgling, Hatchling, Weanling)

4 days

sodium carbonate Acute EC50 199.82 mg/L Fresh water

Daphnia - Daphnia magna 48 hours

Acute LC50 300000 ug/L Fresh water

Daphnia - Daphnia magna 96 hours

Acute LC50 >5600 ppm Fresh water

Fish - Morone saxatilis - Larvae 48 hours

Acute LC50 1000000 ug/L Fresh water

Fish - Morone saxatilis - Larvae 96 hours

Conclusion/Summary

The mixture is toxic to aquatic organisms.

Page 13: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 13 of 17

12.2 Persistence and degradability

Conclusion/Summary The organic components of this product are considered to be biodegradable.

12.3 Bio accumulative potential

Not available.

12.4 Mobility in soil

Soil/water partition coefficient (KOC)

Not available.

Mobility The components are all water soluble and are expected to partition to the aquatic compartment.

12.5 Results of PBT and vPvB assessment

PBT A PBT / vPvB assessment has not been carried out but none of the components are expected to possess these properties.

vPvB As above.

12.6 Other adverse effects No known significant effects or critical hazards.

SECTION 13. DISPOSAL CONSIDERATIONS

The information in this section contains generic advice and guidance. The list of Identified Uses in Section 1 should be consulted for any available use-specific information provided in the Exposure Scenario(s). 13.1 Waste treatment methods Product

Methods of disposal

The generation of waste should be avoided or minimised wherever possible. Significant quantities of waste product residues should not be disposed of via the foul sewer but processed in a suitable effluent treatment plant. Dispose of surplus and non-recyclable products via a licensed waste disposal contractor. Disposal of this product, solutions and any by-products should at all times comply with the requirements of environmental protection and waste disposal legislation and any Regional local authority requirements. Small amounts can be made as per manufacturer’s instructions and disposed of via the foul sewer with plenty of cold running water.

Hazardous waste The classification of the product may meet the criteria for a hazardous waste.

Packaging

Methods of disposal

The generation of waste should be avoided or minimised wherever possible. Sachets should not be cleaned, rinsed or recycled.

Special precautions

This material and its container must be disposed of in a safe way. Care should be taken when handling emptied containers that have not been cleaned or rinsed out. Empty containers or liners may retain some product residues. Avoid dispersal of spilt material and runoff and contact with soil, waterways, drains and sewers.

Page 14: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 14 of 17

SECTION 14. TRANSPORT INFORMATION

ADR/RID ADN/ADNR IMDG IATA

14.1 UN number UN1479 UN1479 UN1479 UN1479

14.2 UN proper shipping name

OXIDIZING SOLID, N.O.S.,(Sodium chlorite)

OXIDIZING SOLID, N.O.S.,(Sodium chlorite)

OXIDIZING SOLID, N.O.S.,(sodium chlorite), Marine pollutant.

OXIDIZING SOLID, N.O.S.,(Sodium chlorite)

14.3 Transport hazard class(es)

5.1

14.4 Packing group

III III III III

14.5 Environmental hazards

Yes Yes Yes Yes

14.6 Special precautions for user

Not available. Not available. Not available. Not available.

Additional information

Hazard identification Number - 50 Limited quantity 5 kgs Special provisions – 274 Tunnel code - (E)

- Emergency schedules (EMS) F-A, S-Q

Passenger and Cargo Aircraft Quantity limitation: 25 kg Packaging instructions: 516 Cargo Aircraft Only Quantity limitation: 100 kg Packaging instructions: 518 Limited Quantities - Passenger Aircraft Quantity limitation: 10 kg Packaging instructions: Y516

14.7 Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code

Not available.

Page 15: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 15 of 17

SECTION 15. REGULATORY INFORMATION

15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture EU Regulation (EC) No. 1907/2006 (REACH)

Annex XIV - List of substances subject to authorisation Substances of very high concern

None of the components are listed

Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles

Not applicable.

Other EU regulations

Europe inventory All components are listed or exempted.

Black List Chemicals Not listed.

Priority List Chemicals Not listed.

Integrated pollution prevention and control list (IPPC) - Air

Not listed.

Integrated pollution prevention and control list (IPPC) - Water

Not listed.

International regulations

Chemical Weapons Convention List Schedule I Chemicals

Not listed.

Chemical Weapons Convention List Schedule II Chemicals

Not listed.

Chemical Weapons Convention List Schedule III Chemicals

Not listed.

15.2 Chemical Safety Assessment

This product contains substances for which Chemical Safety Assessments are still required.

Page 16: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 16 of 17

SECTION 16. OTHER INFORMATION

Abbreviations and acronyms

ATE = Acute Toxicity Estimate CLP = Classification, Labelling and Packaging Regulation [Regulation (EC) No. 1272/2008] DNEL = Derived No Effect Level EUH statement = CLP-specific Hazard statement PNEC = Predicted No Effect Concentration RRN = REACH Registration Number.

Procedure used to derive the classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Classification Justification

Ox. Sol. 3, H272 Acute Tox. 4, H302 Acute Tox. 3, H311 Acute Tox. 2, H330 Skin Corr. 1B Aquatic Chronic 3, H412 Aquatic Acute 1, H400 STOT RE 2

Expert judgment Calculation method Calculation method Calculation method Calculation method Calculation method Calculation method Calculation method

Full text of abbreviated Hazard statements

H272 May intensify fire; oxidiser. H301 Toxic if swallowed. H302 Harmful if swallowed. H311 Toxic in contact with skin. H315 Causes skin irritation. H319 Causes serious eye irritation. H330 Fatal if inhaled. H400 Very toxic to aquatic life.

Full text of classifications [CLP/GHS]

Acute Tox. 1, H330 ACUTE TOXICITY: INHALATION - Category 1 Acute Tox. 2, H310 ACUTE TOXICITY: SKIN - Category 2 Acute Tox. 2, H330 ACUTE TOXICITY: INHALATION - Category 2 Acute Tox. 3, H301 ACUTE TOXICITY: ORAL - Category 3 Acute Tox. 3, H311 ACUTE TOXICITY: SKIN - Category 3 Acute Tox. 4, H302 ACUTE TOXICITY: ORAL - Category 4 Aquatic Acute 1, H400 AQUATIC TOXICITY (ACUTE) - Category 1 Aquatic Chronic 3, H412 AQUATIC TOXICITY (CHRONIC) - Category 3 Skin Corr. 1B STOT RE 2, H373 Eye Dam. 1 H318 SERIOUS EYE DAMAGE - Category 1 Eye Irrit. 2, H319 SERIOUS EYE DAMAGE/ EYE IRRITATION - Category 2 Ox. Sol. 3, H272 OXIDIZING SOLIDS - Category 3 Skin Irrit. 2, H315 SKIN CORROSION/IRRITATION - Category 2

Page 17: Clinimax Difficil-S Part A SAFETY DATA SHEET Difficil-S Part A …media.supplychain.nhs.uk/media/documents/MFB112/COSHH/66246… · Date of issue/Revision: 06/12/16 1 of 17 SAFETY

Clinimax Difficil-S Part A

Version 3.1, Supersedes Version 3, 29/0716

Date of issue/Revision: 06/12/16 17 of 17

Date of printing -

Date of issue/ Date of revision

06/12/16

Date of previous issue 29/07/16

Version 3

Changes since previous revision:

Artwork and header adjustments

Notice to reader

To the best of our knowledge, the information contained herein is accurate. However, neither the above-named supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or completeness of the information contained herein. Final determination of suitability of any material is the sole responsibility of the user. All materials may present unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot guarantee that these are the only hazards that exist.